Performance measures for alcohol and other drugs services: a commentary

Página do item simplificado
dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorAMARAL, Ricardo Abrantes do
dc.date.accessioned2024-04-05T19:37:21Z
dc.date.available2024-04-05T19:37:21Z
dc.date.issued2023
dc.description.abstractAlcohol and other drugs treatment includes a wide range of service and personal characteristics, along with expected and unexpected barriers to treatment. To capture the benefits and the gaps of a designed treatment, one needs to consider process-of-care and outcome measurements. Process-of-care measures are mainly developments of the rationale proposed by The Washington Circle and capture all variants in the process-of-care as proportions. Outcome measures are strongly related to different concepts of recovery and described as simple yes/no answers type to wide levels of response, such as in Likert-type scales. According to the studies collected here, more realistic periods of data-collection for process-of-care measures and a more reliable format to capture outcome particularities should be designed.eng
dc.description.indexMEDLINE
dc.description.indexPubMed
dc.description.indexScopus
dc.description.indexDimensions
dc.description.indexWoS
dc.identifier.citationINTERNATIONAL REVIEW OF PSYCHIATRY, v.35, n.5-6, Special Issue, p.475-485, 2023
dc.identifier.doi10.1080/09540261.2023.2249093
dc.identifier.eissn1369-1627
dc.identifier.issn0954-0261
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/59114
dc.language.isoeng
dc.publisherTAYLOR & FRANCIS LTDeng
dc.relation.ispartofInternational Review of Psychiatry
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright TAYLOR & FRANCIS LTDeng
dc.subjectSubstance use disordereng
dc.subjectperformanceeng
dc.subjectmeasurementeng
dc.subjectserviceeng
dc.subjectcommentaryeng
dc.subject.otherrecoveryeng
dc.subject.otherfeasibilityeng
dc.subject.wosPsychiatryeng
dc.titlePerformance measures for alcohol and other drugs services: a commentaryeng
dc.typearticleeng
dc.type.categoryrevieweng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.citation.scopus0
hcfmusp.contributor.author-fmusphcRICARDO ABRANTES DO AMARAL
hcfmusp.description.beginpage475
hcfmusp.description.endpage485
hcfmusp.description.issue5-6
hcfmusp.description.issueSpecial Issue
hcfmusp.description.volume35
hcfmusp.origemWOS
hcfmusp.origem.dimensionspub.1164616461
hcfmusp.origem.pubmed38299659
hcfmusp.origem.scopus2-s2.0-85173458602
hcfmusp.origem.wosWOS:001078285500001
hcfmusp.publisher.cityABINGDONeng
hcfmusp.publisher.countryENGLANDeng
hcfmusp.relation.referenceAl-Janabi H, 2012, QUAL LIFE RES, V21, P167, DOI 10.1007/s11136-011-9927-2eng
hcfmusp.relation.referenceAshford RD, 2019, ADDICT RES THEORY, V27, P179, DOI 10.1080/16066359.2018.1515352eng
hcfmusp.relation.referenceBest D, 2020, SUBST ABUSE TREAT PR, V15, DOI 10.1186/s13011-020-00281-7eng
hcfmusp.relation.referenceColeman K, 2009, HEALTH AFFAIR, V28, P75, DOI 10.1377/hlthaff.28.1.75eng
hcfmusp.relation.referenceDavidson L, 2021, ALCOHOL RES-CURR REV, V41, DOI 10.35946/arcr.v41.1.09eng
hcfmusp.relation.referenceDavies G, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/1747-597X-10-2eng
hcfmusp.relation.referenceElison S, 2016, SUBST USE MISUSE, V51, P1195, DOI 10.3109/10826084.2016.1161052eng
hcfmusp.relation.referenceGarnick DW, 2009, J SUBST ABUSE TREAT, V36, P265, DOI 10.1016/j.jsat.2008.06.008eng
hcfmusp.relation.referenceGarnick DW, 2006, ALCOHOL RES HEALTH, V29, P19eng
hcfmusp.relation.referenceGarnick DW, 2002, J SUBST ABUSE TREAT, V23, P375, DOI 10.1016/S0740-5472(02)00303-3eng
hcfmusp.relation.referenceGroshkova T, 2013, DRUG ALCOHOL REV, V32, P187, DOI 10.1111/j.1465-3362.2012.00489.xeng
hcfmusp.relation.referenceKolind T, 2009, INT J SOC WELF, V18, P270, DOI 10.1111/j.1468-2397.2008.00608.xeng
hcfmusp.relation.referenceLaudet A., 2013, Life in Recovery"": Report on the survey findingseng
hcfmusp.relation.referenceLaudet AB, 2009, J SUBST ABUSE TREAT, V37, P182, DOI 10.1016/j.jsat.2009.01.001eng
hcfmusp.relation.referenceMcCorry F, 2000, Jt Comm J Qual Improv, V26, P633eng
hcfmusp.relation.referenceMCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-Seng
hcfmusp.relation.referenceMiller, 2014, ASAM PERFORMANCE MEAeng
hcfmusp.relation.referenceMorisano D, 2014, NORD STUD ALCOHOL DR, V31, P5, DOI 10.2478/nsad-2014-0002eng
hcfmusp.relation.referenceNational Academies of Sciences Engineering and Medicine, 2020, MEAS SUCC SUBST US Geng
hcfmusp.relation.referenceNeale J, 2015, DRUG-EDUC PREV POLIC, V22, P26, DOI 10.3109/09687637.2014.947564eng
hcfmusp.relation.referenceNeale J, 2014, DRUG-EDUC PREV POLIC, V21, P310, DOI 10.3109/09687637.2014.918089eng
hcfmusp.relation.referenceRobinson SM, 2014, PSYCHOL ADDICT BEHAV, V28, P154, DOI 10.1037/a0030992eng
hcfmusp.relation.referenceSAMHSA, 2010, Recovery-Oriented Systems of Care (ROSC) resource guideeng
hcfmusp.relation.referenceSavic M, 2017, SUBST ABUSE TREAT PR, V12, DOI 10.1186/s13011-017-0104-7eng
hcfmusp.relation.referenceSubstance Abuse and Mental Health Services Administration, 2018, HHS Publication No. SMA 18-5068, NSDUH Series H-53, V18eng
hcfmusp.relation.referenceThomas CP, 2013, J SUBST ABUSE TREAT, V45, P11, DOI 10.1016/j.jsat.2013.01.004eng
hcfmusp.relation.referenceWorld Health Organization, 2022, WORLD MENT HLTH REPeng
hcfmusp.relation.referenceYule AM, 2019, ALCOHOL RES-CURR REV, V40, P61, DOI 10.35946/arcr.v40.1.07eng
hcfmusp.scopus.lastupdate2024-04-12
relation.isAuthorOfPublication68ac7951-dc91-43ce-8baf-a956723e2907
relation.isAuthorOfPublication.latestForDiscovery68ac7951-dc91-43ce-8baf-a956723e2907
Arquivos
Coleções
Artigos e Materiais de Revistas Científicas - HC/IPer